Miglitol’s anti-obesity effect was attributed to increased energy expenditure by upregulating UCP1 in BAT (i.e., by thermogenesis) and to enhancement of β3-adrenergic signaling in BAT. This evidence concerns the gene UCP1 and obesity due to melanocortin 4 receptor deficiency.